Inhaled pre-prandial human insulin

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Inhaled pre-prandial human insulin, covering 2017-03-01 to 2018-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes [Phase 3]